Promising target improves antitumor response in preclinical models of pancreatic cancer

Researchers at The University of Texas MD Anderson Cancer Center have found that a mitochondrial enzyme, GFER, creates an immunosuppressive environment within pancreatic tumors, leading to treatment resistance.

Continue Reading

News Source: medicalxpress.com